For instance, both CD4+ as well as CD8+ T cells upon encounter with melanoma tumor cells, capture NKG2D (natural killer group 2, member D) and NKp46 (natural killer cell receptor 46) ligands by trogocytosis from the tumor cells. The gene discussed is KLRK1; the disease is neoplasm.